Verve Therapeutics Ratios and Metrics

Market cap in millions BDT. Fiscal year is January - December.

Millions BDT. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	7,699	6,695	9,362	9,346	11,033	8,356	Upgrade
Market Cap Growth	-14.58%	-28.49%	0.17%	-15.29%	32.04%	-2.00%	Upgrade
Last Close Price	6.90	6.00	8.06	7.82	8.94	6.59	Upgrade
PE Ratio	9.16	8.08	6.78	8.33	14.17	7.72	Upgrade
PS Ratio	1.21	1.05	1.36	1.44	1.86	1.19	Upgrade
PB Ratio	0.41	0.36	0.51	0.53	0.64	0.50	Upgrade
Debt / Equity Ratio	1.61	1.21	0.87	1.16	1.12	0.73	Upgrade
Return on Equity (ROE)	4.51%	4.48%	7.65%	6.42%	4.58%	6.55%	Upgrade
Return on Assets (ROA)	0.31%	0.32%	0.56%	0.49%	0.35%	0.49%	Upgrade
Earnings Yield	10.92%	12.37%	14.75%	12.00%	7.06%	12.95%	Upgrade
FCF Yield	31.53%	-69.32%	-179.91%	-68.14%	-83.56%	-21.21%	Upgrade
Dividend Yield	3.53%	-	3.02%	3.04%	3.10%	3.42%	Upgrade
Payout Ratio	32.38%	32.85%	19.23%	28.40%	32.30%	44.27%	Upgrade
Total Shareholder Return	3.53%	-	3.02%	3.04%	3.10%	3.42%	Upgrade

Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Banks template. Financial Sources.